Take a breath: How employers can navigate new GLP-1 pricing
While the latest GLP-1 pricing headlines offer hope for individuals looking to access these medications at a lower cost, they raise concerns for employers and payers who must navigate utilization, coverage gaps, and budget implications. GLP-1 costs may appear more predictable under the the latest most-favored-nation (MFN) pricing deals. However, the ‘$149 a month’ headlines may create a false […]